Ingrid Ljuslinder

Ingrid Ljuslinder

UNVERIFIED PROFILE

Are you Ingrid Ljuslinder?   Register this Author

Register author
Ingrid Ljuslinder

Ingrid Ljuslinder

Publications by authors named "Ingrid Ljuslinder"

Are you Ingrid Ljuslinder?   Register this Author

32Publications

1316Reads

7Profile Views

The BRCA1 exon 13 duplication: clinical characteristics of 22 families in Northern Sweden.

Fam Cancer 2019 01;18(1):37-42

Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10689-018-0098-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323134PMC
January 2019

Plasma miRNA can detect colorectal cancer, but how early?

Cancer Med 2018 05 23;7(5):1697-1705. Epub 2018 Mar 23.

Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.1398DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5943420PMC
May 2018

MicroRNA Expression in - and -mutated Colorectal Cancers.

Anticancer Res 2018 02;38(2):677-683

Department of Medical Biosciences, Pathology, Umeå University, Umea, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21873/anticanres.12272DOI Listing
February 2018

A prospective study of the immune system activation biomarker neopterin and colorectal cancer risk.

J Natl Cancer Inst 2015 Apr 23;107(4). Epub 2015 Feb 23.

Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbrueke, Nuthetal, Germany (KA, HB); Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK (SCC, BBdM, MJG, YL, AJC, ER, PV); Division of Health Policy Translation, Institutes of Population Health Sciences, National Health Research Institutes, Miaoli, Taiwan (SCC); Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway (HZ, GST); Molecular Epidemiology Group, Max Delbrueck Center for Molecular Medicine, Berlin-Buch, Germany (TP); International Agency for Research on Cancer, Lyon, France (MJe, SYJK, HF, MJo); National Institute for Public Health and the Environment, Bilthoven, the Netherlands (BBdM); Department of Gastroenterology and Hepatology, University Medical Center, Utrecht, the Netherlands (BBdM); Department of Public Health and Primary Health Care, University of Bergen, Bergen, Norway (SEV); Division of Epidemiology, Norwegian Institute of Public Health, Bergen, Norway (SEV); Bevital AS, Bergen, Norway (ØM); Section for Pharmacology, Department of Clinical Science, University of Bergen, Bergen, Norway (HZ, PMU); Laboratory of Clinical Biochemistry, Haukeland University Hospital, Bergen, Norway (PMU); Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA (VF); Winship Cancer Institute, Emory University, Atlanta, GA (VF); Department of Community Medicine, Faculty of Health Sciences, University of Tromsø, The Arctic University of Norway, Tromsø, Norway (EW); Department of Research, Cancer Registry of Norway, Oslo, Norway (EW); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (EW); Samfundet Folkhälsan, Helsinki, Finland (EW); Human Genetics Foundation (HuGeF), Torino, Italy (GS, PV); Inserm, Centre for research in Epidemiology and Population Health, U1018, Nutrition, Hormones and Women's Health team, F-94805, Villeju

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4402364PMC
April 2015

Human papillomavirus antibodies and future risk of anogenital cancer: a nested case-control study in the European prospective investigation into cancer and nutrition study.

J Clin Oncol 2015 Mar 9;33(8):877-84. Epub 2015 Feb 9.

Aimée R. Kreimer, Krystle A. Lang Kuhs, and Allan Hildesheim, National Cancer Institute, National Institutes of Health, Bethesda, MD; Pagona Lagiou and Dimitrios Trichopoulos, Harvard School of Public Health, Boston, MA; Paul Brennan, Gary Clifford, Silvia Franceschi, and Mattias Johansson, International Agency for Research on Cancer, Lyon; Françoise Clavel-Chapelon, Marie-Christine Boutron-Ruault, and Sylvie Mesrine, Institut National de la Santé et de la Recherche Médicale, Centre for Research in Epidemiology and Population Health; Université Paris Sud; and Institut Gustave Roussy, Villejuif, France; Tim Waterboer, Angelika Michel, Martina Willhauck-Fleckenstein, Renée Turzanski Fortner, Rudolf Kaaks, and Michael Pawlita, German Cancer Research Center, Heidelberg; Heiner Boeing and Annika Steffen, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; Elio Riboli, Amanda J. Cross, H. Bas Bueno-de-Mesquita, and Paolo Vineis, School of Public Health, Imperial College, London; Kay-Tee Khaw and Nicholas Wareham, University of Cambridge, Cambridge; Ruth C. Travis, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom; Xavier Castellsagué, Institut Català d'Oncologia, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Consorcio de Investigación Biomédica en Red Epidemiología y Salud Pública (CIBERESP), L'Hospitalet de Llobregat; Nerea Larrañaga, María-José Sánchez, Carmen Navarro, and Aurelio Barricarte, Consorcio de Investigación Biomédica en Red Epidemiología y Salud Pública, Madrid; María-José Sánchez, Escuela Andaluza de Salud Pública. Instituto de Investigación Biosanitaria, Hospitales Universitarios de Granada/Universidad de Granada, Granada; Carmen Navarro, Murcia Regional Health Council and Universidad de Murcia, Murcia; Aurelio Barricarte, Navarre Public Health Institute, Pamplona; J. Ramón Quirós, Public Health Directorate, Asturias; Nerea Larrañaga, Basque Regional Healt

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.57.8435DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4348636PMC
March 2015

Isolated hepatic perfusion as a treatment for uveal melanoma liver metastases (the SCANDIUM trial): study protocol for a randomized controlled trial.

Trials 2014 Aug 9;15:317. Epub 2014 Aug 9.

Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, Blå stråket 5, 413 45 Gothenburg, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1745-6215-15-317DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4138407PMC
August 2014

Loss of LRIG1 locus increases risk of early and late relapse of stage I/II breast cancer.

Cancer Res 2014 Jun;74(11):2928-35

Authors' Affiliations: Department of Cellular and Molecular Medicine, The University of Arizona Cancer Center, Tucson, Arizona; Department of Pediatrics, Baylor College of Medicine, One Baylor Plaza; Dan L. Duncan Center, Baylor College of Medicine; Departments of Clinical Cancer Prevention and Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas; and Department of Radiation Sciences, Umeå University, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-13-2112DOI Listing
June 2014

Weight change later in life and colon and rectal cancer risk in participants in the EPIC-PANACEA study.

Am J Clin Nutr 2014 Jan 13;99(1):139-47. Epub 2013 Nov 13.

Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Netherlands (CNSB, CHvG, EMM, PHMP, and AMM); the National Institute for Public Health and the Environment, Bilthoven, Netherlands (HBB-d-M); the Department of Gastroenterology and Hepatology, University Medical Centre, Utrecht, Netherlands (HBB-d-M); the Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbrücke, Nuthetal, Germany (HB and KA); the International Agency for Research on Cancer, WHO, Lyon, France (MJ, HF, and PF); the Division of Epidemiology, Public Health and Primary Care, Imperial College, London, United Kingdom (HBB-d-M, TN, ER, and PHMP); INSERM, Centre for Research in Epidemiology and Population Health, Nutrition, Hormones and Women's Health Team, Villejuif, France (MB-R, GF, and AR); University of Paris, Sud, Villejuif, France (MB-R, GF, and AR); IGR, Villejuif, France (MB-R, GF, and AR); Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute-ISPO, Florence, Italy (DP); the Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy (VK); the Cancer Registry and Histopathology Unit, "Civile M.P. Arezzo" Hospital, ASP Ragusa, Italy (RT); HuGeF-Human Genetics Foundation-Torino, Molecular and Genetic Epidemiology Unit, Torino, Italy (A Naccarati); Dipartimento di Medicina Clinica e Chirugia, FEDERICO II University, Naples, Italy (AM); Public Health Directorate, Asturias, Spain (MVA); the Andalusian School of Public Health, Granada, Spain (MS and MJT); CIBER de Epidemiología y Salud Pública, Spain (MS, MJT, and EA); the Department of Epidemiology, Murcia Regional Health Council, Murcia, Spain (MJT); the Department of Health and Social Sciences, Universidad de Murcia, Murcia, Spain (MJT); the Navarre Public Health Institute, Pamplona, Spain (EA); Subdirección de Salud Pública de Gipuzkoa, Gobierno Vasco, San Sebastian, Spain (MD); the Department of Epidemiology, Catalan I

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3945/ajcn.113.066530DOI Listing
January 2014

Plasma alkylresorcinols, biomarkers of whole-grain wheat and rye intake, and incidence of colorectal cancer.

J Natl Cancer Inst 2014 Jan 7;106(1):djt352. Epub 2013 Dec 7.

Affiliations of authors: Danish Cancer Society Research Center, Copenhagen, Denmark (CK, AO, JC, AT); Department of Food Science, BioCenter, Swedish University of Agricultural Sciences, Uppsala, Sweden (RL, PÅ); Department of Community Medicine, University of Tromsø, Tromsø, Norway (GS, EW, TB, LAÅ); Department of Public Health, Section of Environmental Health, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark (SL); Department of Gastroenterology and Hepatology (ML, VKD, PDS, BB) and Department of Epidemiology, Julius Center for Health Sciences and Primary Care (PHP), University Medical Center Utrecht, Utrecht, The Netherlands; Molecular Epidemiology Group, Max Delbrueck Center for Molecular Medicine Berlin-Buch, Berlin, Germany (TP); Department of Public Health, Section of Epidemiology, Aarhus University, Aarhus, Denmark (KO); Inserm, Centre for Research in Epidemiology and Population Health (CESP), U1018, Nutrition, Hormones and Women's Health team, F-94805, Villejuif, France (M-CB-R, GF, VC); Univ Paris Sud, UMRS 1018, F-94805, Villejuif, France (M-CB-R, GF, VC); IGR, F-94805, Villejuif, France (M-CB-R, GF, VC); German Cancer Research Center, DKFZ, Division of Cancer Epidemiology, Heidelberg, Germany (TK, JC-C); Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany (HB); Hellenic Health Foundation, Athens, Greece (ATR, CB, DT); WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School, Athens, Greece (ATR, CB); Department of Epidemiology, Harvard School of Public Health, Boston, MA (DT); Bureau of Epidemiologic Research, Academy of Athens, Athens, Greece (DT); Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute-ISPO, Florence, Italy (DP); Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy (VK); Cancer Registry and His

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djt352DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906988PMC
January 2014

Co-incidental increase in gene copy number of ERBB2 and LRIG1 in breast cancer.

Breast Cancer Res 2009 12;11(3):403. Epub 2009 May 12.

Department of Radiation Sciences, Oncology, Umeå University Hospital, Umeå, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/bcr2248DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2716489PMC
January 2010

ErbB 1-4 expression alterations in primary colorectal cancers and their corresponding metastases.

Anticancer Res 2009 May;29(5):1489-94

Department of Radiation sciences, Oncology, Umeå University Hospital, Umeå University SE-90187 Umeå, Sweden.

View Article

Download full-text PDF

Source
May 2009

Mammaglobin and lipophilin B expression in breast tumors and their lack of effect on breast cancer cell proliferation.

Anticancer Res 2008 May-Jun;28(3A):1493-8

Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.

View Article

Download full-text PDF

Source
July 2008

LRIG1 expression in colorectal cancer.

Acta Oncol 2007 ;46(8):1118-22

Department of Radiation Sciences, Oncology, Umeå University Hospital, Umeå University, Umeå, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/02841860701426823DOI Listing
April 2008